- Home
- SONN vs MOVE Comparison
SONN vs MOVE Comparison
Compare SONN & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- MOVE
- Stock Information
- Founded
- SONN N/A
- MOVE 2018
- Country
- SONN United States
- MOVE United States
- Employees
- SONN N/A
- MOVE N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SONN Health Care
- MOVE Health Care
- Exchange
- SONN Nasdaq
- MOVE Nasdaq
- Market Cap
- SONN 3.8M
- MOVE 4.2M
- IPO Year
- SONN N/A
- MOVE 2021
- Fundamental
- Price
- SONN $1.17
- MOVE $0.67
- Analyst Decision
- SONN Strong Buy
- MOVE Buy
- Analyst Count
- SONN 1
- MOVE 1
- Target Price
- SONN $20.00
- MOVE $30.00
- AVG Volume (30 Days)
- SONN 35.1K
- MOVE 922.3K
- Earning Date
- SONN 05-13-2025
- MOVE 06-10-2025
- Dividend Yield
- SONN N/A
- MOVE N/A
- EPS Growth
- SONN N/A
- MOVE N/A
- EPS
- SONN N/A
- MOVE N/A
- Revenue
- SONN $1,000,000.00
- MOVE $1,013,000.00
- Revenue This Year
- SONN $5,376.22
- MOVE $1,460.71
- Revenue Next Year
- SONN N/A
- MOVE N/A
- P/E Ratio
- SONN N/A
- MOVE N/A
- Revenue Growth
- SONN 978.39
- MOVE N/A
- 52 Week Low
- SONN $1.08
- MOVE $0.51
- 52 Week High
- SONN $16.00
- MOVE $6.97
- Technical
- Relative Strength Index (RSI)
- SONN 41.23
- MOVE 37.34
- Support Level
- SONN $1.08
- MOVE $0.51
- Resistance Level
- SONN $1.21
- MOVE $0.69
- Average True Range (ATR)
- SONN 0.07
- MOVE 0.14
- MACD
- SONN -0.01
- MOVE 0.01
- Stochastic Oscillator
- SONN 29.03
- MOVE 12.69
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.